Medtronic (MDT) Current Deferred Revenue (2025 - 2026)
Medtronic's (MDT) quarterly Current Deferred Revenue came in at $283.0 million in Q1 2026, down 11.01% quarter-over-quarter from $318.0 million in Q4 2025.
Medtronic (MDT) Current Deferred Revenue (2025 - 2026) Analysis & Trends
Medtronic has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $283.0 million for Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $283.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2026 was $283.0 million (changed N/A YoY), and the FY2025 annual result was $391.0 million, changed N/A from the prior year.
- Current Deferred Revenue came in at $283.0 million for Q1 2026 at Medtronic, down from $318.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $391.0 million in Q2 2025 to a low of $283.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | 283.00 Mn |
| Oct 24, 2025 | 318.00 Mn |
| Jul 25, 2025 | 355.00 Mn |
| Apr 25, 2025 | 391.00 Mn |